Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. One was a Tax Payment of $18,400.36 and the other was a Sale of $78,822.38. Average transaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results